Business
-
BioCina and NovaCina Merger Bolsters Global CDMO IndustryDetails
ADELAIDE,South Australia and PERTH,Western Australia,Jan. 14,2025-- Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will cre
-
COSRX Celebrates Global Success at SeoulCon's K-Beauty Boost EventDetails
NEW YORK,Jan. 13,2025--COSRX,a trailblazer in the K-Beauty industry,wrapped up 2024 on a high note by participating in the K-Beauty Boost at SeoulCon,a prominent year-end creator conference hosted by
-
LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025Details
Exhibition booth attracts 65,000 cumulative visitors,showcasing innovative mobility components Innovative technologies presented through a \'User-Centric storytelling\' approach elicit strong acclaim
-
Nature's Miracle Holding, Inc. Announces Up to $29.7 Million FinancingDetails
ONTARIO,Calif.,Jan. 13,2025-- Nature\'s Miracle Holding,Inc. (Nasdaq: NMHI) ("Nature\'s Miracle"),a growing agriculture technology company providing equipment and services to growers,announc
-
BOUNTEOUS x ACCOLITE TO REBRAND AS BOUNTEOUSDetails
Merger creating global leader in digital transformation services hits one year mark CHICAGO,Jan. 14,2025-- Bounteous x Accolite today announced that it will unify under the Bounteous brand name globa
-
BioCina and NovaCina Merger Bolsters Global CDMO IndustryDetails
ADELAIDE,South Australia and PERTH,Western Australia,Jan. 14,2025-- Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a strategic merger that will cre
-
2024 Marks Breakout Year for China's ETF Market with Unprecedented GrowthDetails
GUANGZHOU,China,Jan. 10,2025--China\'s ETF market demonstrated exceptional performance in 2024,with notable returns and substantial growth in assets under management. According to Wind,the average re
-
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic SurgeryDetails
Funding from leading investors to accelerate R&D and international expansion to make robotic surgery solutions accessible to more
-
Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of ObesityDetails
Regor announced its 12-week single-dose Phase 2a trial results for RGT-075,a once-daily oral GLP-1RA,reporting 5% placebo-adjusted weight-loss with no plateau
-
2024 Marks Breakout Year for China's ETF Market with Unprecedented GrowthDetails
GUANGZHOU,China,Jan. 10,2025--China\'s ETF market demonstrated exceptional performance in 2024,with notable returns and substantial growth in assets under management. According to Wind,the average re